FDA issues recalls on at least 16 food and drug items in September. Here's a list
The FDA has removed the following items from store shelves this September, including pet food, baby powder and Lactaid.
STAT5d
Q&A: How the FDA is approaching AI in clinical trials and drug development
The FDA's Tala Fakhouri discusses the agency's approach to the regulation of AI in clinical trials in a new interview.
The Tribune-Democrat3dOpinion
Andrei Iancu and David Kappos | Proposed drug patent reforms would do more harm than good
Congress is considering a bill that could exacerbate government waste and give American companies’ most valuable trade ...
Business Wire16d
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of ...
today announced that the U.S. Food and Drug Administration (FDA) has approved COBENFY™ (xanomeline and trospium chloride), an oral medication for the treatment of schizophrenia in adults.
JD Supra6d
GLP-1 Drugs: FDA Removes Lilly’s Zepbound® and Mounjaro® (tirzepatide injection) from its Drug Shortage List
On October 2, 2024, the U.S. Food and Drug Administration (FDA) determined the shortage of the tirzepatide injection, a glucagon-like peptide ...
NBC New York18d
FDA issues recall notices over 2 brands of pet food due to salmonella and listeria risk
Amid an ongoing pet food recall, the U.S. Food and Drug Administration (FDA) is urging pet owners not to give their ...
agdaily6d
10 careers in food science: Driving innovation and sustainability in the food industry
Careers in food science not only focus on improving food quality but also on addressing challenges like food security, waste ...
The Associated Press on MSN11d
Restaurants, Food and Drink
The state is the first to ban food labels such as “sell by” or “best before” under a law signed by Gov. Newsom. The ...
WHYY5d
Philadelphia health providers and patients seek a new treatment roadmap for sickle cell disease after drug recall
Voxelotor, which was sold under the brand name Oxbryta, was suddenly pulled from the market over safety concerns from ...
SCOTUSblog10d
Food and Drug Administration v. R.J. Reynolds Vapor Co.
Issue: Whether a manufacturer may file a petition for review in a circuit (other than the U.S. Court of Appeals for the District of Columbia Circuit) where it neither resides nor has its principal ...
policymed.com9h
Mirati Therapeutics Receives Untitled Letter from OPDP for Overstating Cancer Drug Efficacy
Office of Prescription Drug Promotion (OPDP) recently sent an untitled letter to Mirati Therapeutics for claims made by the ...